| Recruiting | The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational NCT07309562 | Xiamen Amoytop Biotech Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Accuracy of Interstitial Continuous Glucose Sensors in Neonates NCT07133906 | Women and Infants Hospital of Rhode Island | — |
| Unknown | Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Ch NCT05603936 | Universitätsklinikum Hamburg-Eppendorf | — |
| Completed | A Trial of YPEG-rhGH in Children With Short Stature NCT05838885 | Xiamen Amoytop Biotech Co., Ltd. | Phase 2 |
| Recruiting | Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature NCT04798690 | Dong-A ST Co., Ltd. | — |
| Unknown | Ultrasound Evaluation of Fetal Hemodynamics and Perinatal Complications NCT03865628 | Centre Hospitalier Universitaire de Besancon | — |
| Terminated | Micronutrient Supplementation Before and During 1st Pregnancy to Improve Birth Outcomes (JiVitA-5) NCT03921177 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Unknown | Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age NCT02964793 | University Hospital, Grenoble | N/A |
| Completed | Cardiovascular Screening in Infants Born Small for Gestational Age NCT03758092 | Azienda Ospedaliero Universitaria Maggiore della Carita | — |
| Recruiting | Investigating the Structured Use of Ultrasound Scanning for Fetal Growth NCT03662178 | Oxford University Hospitals NHS Trust | — |
| Unknown | Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children NCT02931591 | Cambridge University Hospitals NHS Foundation Trust | N/A |
| Completed | Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in Ba NCT02745249 | International Food Policy Research Institute | N/A |
| Completed | Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. NCT02280031 | CHU de Quebec-Universite Laval | Phase 2 |
| Completed | ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes NCT02218931 | Queen Mary University of London | N/A |
| Completed | Growth and Asymmetric diMethylArginine NCT03422081 | University Hospital, Lille | — |
| Recruiting | Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children NCT01604395 | LG Chem | — |
| Completed | Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated NCT01327924 | Novo Nordisk A/S | — |
| Completed | Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents NCT01245374 | Novo Nordisk A/S | Phase 4 |
| Completed | Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age NCT01110928 | Novo Nordisk A/S | — |
| Completed | Epigenetic Markers of B-Cell Function in Low Birth Weight Infants NCT00925925 | University of Utah | — |
| Completed | Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects NCT00787878 | Novo Nordisk A/S | — |
| Completed | Long Term Use of Somatropin in Patients Small for Gestational Age NCT00793325 | Pfizer | — |
| Completed | Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA) NCT00537914 | Sandoz | Phase 4 |
| Terminated | Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH) NCT00597480 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Completed | Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector NCT00738205 | Merck KGaA, Darmstadt, Germany | — |
| Completed | French National Registry of Children Born Small for Gestational Age Treated With Somatropin NCT01578135 | Novo Nordisk A/S | — |
| Completed | Maternal Obesity and Small for Gestational Age Infants NCT00371657 | Oklahoma State University Center for Health Sciences | — |
| Completed | Observational Prospective Study on Patients Treated With Norditropin® NCT00960128 | Novo Nordisk A/S | — |
| Completed | Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction NCT00519844 | Novo Nordisk A/S | Phase 4 |
| Completed | Growth Hormone Treatment in Children Born Small for Gestational Age (SGA) NCT00184717 | Novo Nordisk A/S | Phase 3 |
| Terminated | Constructing an Insulin-Like Growth Factor-based Prediction Model NCT00263445 | University of California, Los Angeles | — |
| Completed | Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age NCT00557336 | Novo Nordisk A/S | Phase 3 |
| Completed | Efficacy on Height in SGA Children Treated With Growth Hormone NCT00184756 | Novo Nordisk A/S | Phase 3 |
| Completed | Safety and Efficacy of Long-term Somatropin Treatment in Children NCT01543867 | Novo Nordisk A/S | — |
| Completed | Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation NCT01734447 | Novo Nordisk A/S | Phase 4 |
| Completed | Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years NCT00184691 | Novo Nordisk A/S | Phase 3 |
| Completed | Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation NCT01697644 | Novo Nordisk A/S | Phase 4 |